Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Platelet-derived growth factor (PDGF) is a potent mitogenic and migratory factor that regulates the tyrosine phosphorylation of a variety of signalling proteins via intracellular production of H2O2 (refs 1, 2-3). Mammalian 2-Cys peroxiredoxin type II (Prx II; gene symbol Prdx2) is a cellular peroxidase that eliminates endogenous H2O2 produced in response to growth factors such as PDGF and epidermal growth factor; however, its involvement in growth factor signalling is largely unknown. Here we show that Prx II is a negative regulator of PDGF signalling. Prx II deficiency results in increased production of H2O2, enhanced activation of PDGF receptor (PDGFR) and phospholipase Cgamma1, and subsequently increased cell proliferation and migration in response to PDGF. These responses are suppressed by expression of wild-type Prx II, but not an inactive mutant. Notably, Prx II is recruited to PDGFR upon PDGF stimulation, and suppresses protein tyrosine phosphatase inactivation. Prx II also leads to the suppression of PDGFR activation in primary culture and a murine restenosis model, including PDGF-dependent neointimal thickening of vascular smooth muscle cells. These results demonstrate a localized role for endogenous H2O2 in PDGF signalling, and indicate a biological function of Prx II in cardiovascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, cells isolated from mice with deficiencies in Prx1 or Prx2 show increased production of hydrogen peroxide and increased sensitivity to oxidant damage (88, 239, 313).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [88]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Structure, mechanism and regulation of peroxiredoxins
Wood, Z. A., Schröder, E., Robin Harris, J., & Poole, L. B. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)00003-8 · Cited by 2,544
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., & Finkel, T. (1995) · Science · doi:10.1126/science.270.5234.296 · Cited by 2,520 · cited 1×
“Our studies have revealed two new signalling mechanisms: (1) endogenous H2O2 mediates the site-selective amplification of PDGFR phosphorylation; and (2) Prx II is a physiological regulator of endogenous H2O2 signal.”
BackgroundMechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C.-H., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,496 · cited 1×
“Our studies have revealed two new signalling mechanisms: (1) endogenous H2O2 mediates the site-selective amplification of PDGFR phosphorylation; and (2) Prx II is a physiological regulator of endogenous H2O2 signal.”
BackgroundInhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF
Ferns, G. A. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., & Ross, R. (1991) · Science · doi:10.1126/science.1653454 · Cited by 1,065
Regulation of Phosphoinositide-specific Phospholipase C Isozymes
Rhee, S. G., & Bae, Y. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15045 · Cited by 876
Self-citationKang, S. W., Chae, H. Z., Seo, M. S., Kim, K., Baines, I. C., & Rhee, S. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6297 · Cited by 692
Self-citationHydrogen Peroxide: A Key Messenger That Modulates Protein Phosphorylation Through Cysteine Oxidation
Rhee, S. G., Bae, Y. S., Lee, S.-R., & Kwon, J. (2000) · Science's STKE · doi:10.1126/stke.2000.53.pe1 · Cited by 644
Self-citationPeroxiredoxin, a Novel Family of Peroxidases
Rhee, S. G., Kang, S. W., Chang, T., Jeong, W., & Kim, K. (2001) · IUBMB Life · doi:10.1080/15216540252774748 · Cited by 639
Self-citationKim, H. K., Kim, J. W., Zilberstein, A., Margolis, B., Kim, J. G., Schlessinger, J., & Rhee, S. G. (1991) · Cell · doi:10.1016/0092-8674(91)90461-7 · Cited by 570
Self-citation
Cited by
Items 101–200 of 402
Quercetin protects gastric epithelial cell from oxidative damage in vitro and in vivo
Hu, X., Ding, C., Zhou, N., & Chen, X. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.007 · Cited by 103
Peroxiredoxins wear many hats: Factors that fashion their peroxide sensing personalities
Bolduc, J. A., Koruza, K., Luo, T., Pueyo, J. M., Vo, T. N., Ezeriņa, D., & Messens, J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101959 · Cited by 108
Laminar Shear Stress Up-regulates Peroxiredoxins (PRX) in Endothelial Cells
Mowbray, A. L., Kang, D.-H., Rhee, S. G., Kang, S. W., & Jo, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707985200 · Cited by 93
Self-citationMaller, C., Schröder, E., & Eaton, P. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3149 · Cited by 93
“However, in at least some cases, the H2O2, which is simultaneously produced, is crucial in achieving the full complement of cellular responses (14).”
BackgroundDing, Y., Yamada, S., Wang, K., Shimajiri, S., Guo, X., Tanimoto, A., Murata, Y., Kitajima, S., Watanabe, T., Izumi, H., et al. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3137 · Cited by 95
Role of sestrin2 in peroxide signaling in macrophages
Essler, S., Dehne, N., & Brüne, B. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.017 · Cited by 89
Jönsson, T. J., Murray, M. S., Johnson, L. C., & Lowther, W. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803244200 · Cited by 91
Morinaka, A., Funato, Y., Uesugi, K., & Miki, H. (2011) · Oncogene · doi:10.1038/onc.2011.139 · Cited by 97
Redox Control of Vascular Smooth Muscle Migration
San Martín, A., & Griendling, K. K. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2852 · Cited by 89
“Prx II overexpression in VSMCs inhibits migration in vitro (32).”
Localized redox relays as a privileged mode of cytoplasmic hydrogen peroxide signaling
Travasso, R. D. M., Sampaio dos Aidos, F., Bayani, A., Abranches, P., & Salvador, A. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.003 · Cited by 86
“A small fraction of the cytoplasmic 2-Cys peroxiredoxins can be recruited to the cellular membrane [51,25,37] or to the centrosome [38], where they can protect sensitive proteins against oxidation by H2O2 [37,38].”
BackgroundInfluentialThe role of peroxidases in the pathogenesis of atherosclerosis
Park, J., & Oh, G.-T. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.8.497 · Cited by 94
“vating protein, the protein-tyrosine phosphatase SHP-2, phospholipase C-γ1 (PLC-γ1) (70, 71).”
Singh, S. A., Isken, F., Agelopoulos, K., Klein, H., Thoennissen, N. H., Koehler, G., Hascher, A., Bäumer, N., Berdel, W. E., Thiede, C., et al. (2011) · Blood · doi:10.1182/blood-2011-06-358705 · Cited by 90
“Because PRDX2 expression did not differ between the cytogenetic AML subgroups, further analyses were performed in patients with intermediate cytogenetics (all with normal karyotype and those without inv(16), t(8;21), t(15;17), complex karyotype, monosomy 7, or trisomy 8).”
Self-citationKinnula, V. L., & Myllärniemi, M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1942 · Cited by 97
“The PDGF receptor production of H2O2 is tightly controlled by peroxiredoxin II (27).”
Wei, Q., Jiang, H., Matthews, C. P., & Colburn, N. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810676105 · Cited by 85
Protein tyrosine phosphatase structure–function relationships in regulation and pathogenesis
Böhmer, F., Szedlacsek, S. E., Tabernero, L., Östman, A., & den Hertog, J. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08655.x · Cited by 102
Bottani, E., Lamperti, C., Prigione, A., Tiranti, V., Persico, N., & Brunetti, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111083 · Cited by 96
“In physiological conditions, ROS act as signaling molecules through a tightly regulated process in cell proliferation [180], development, immunity, apoptosis, among others [181], while are scavenged by different antioxidant enzymes that include various isoforms of glutathione peroxidase (GP), superoxide dismutase (SOD…”
BackgroundProteomic analysis of phosphorylation, oxidation and nitrosylation in signal transduction
Spickett, C. M., Pitt, A. R., Morrice, N. A., & Kölch, W. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.09.013 · Cited by 92
Siow, R. C. M., & Churchman, A. T. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.007 · Cited by 83
“It is noteworthy that PDGF-BB has been shown not only to enhance superoxide generation in cultured vascular SMC via NAD(P)H oxidase activity [75], but it also modulates expression of peroxiredoxin-II, an endogenous hydrogen peroxide scavenging antioxidant gene [76], in a murine model of vascular injury [77], thus prov…”
BackgroundRole of Cytosolic 2-Cys Prx1 and Prx2 in Redox Signaling
Kim, Y., & Jang, H. H. (2019) · Antioxidants · doi:10.3390/antiox8060169 · Cited by 86
“Consequently, Prx2 acts as a negative regulator of PDGF signaling to inhibit the proliferation and migration of smooth muscle cells [104].”
BackgroundROS up-regulation mediates Ras-induced changes of cell morphology and motility
Alexandrova, A. Y., Kopnin, P., Vasiliev, J. M., & Kopnin, B. P. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.004 · Cited by 86
Platelets Influence Vascularized Organ Transplants from Start to Finish
Kirk, A. D., Morrell, C. N., & Baldwin, W. M. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02473.x · Cited by 75
“PDGF enhances neointimal formation in models of restenosis by stimulating migration, differentiation and proliferation of smooth muscle cells (51).”
BackgroundNovel hyperoxidation resistance motifs in 2-Cys peroxiredoxins
Bolduc, J. A., Nelson, K. J., Haynes, A. C., Lee, J., Reisz, J. A., Graff, A. H., Clodfelter, J. E., Parsonage, D., Poole, L. B., Furdui, C. M., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001690 · Cited by 86
“For example, homeostatic receptor– mediated signaling requires low levels of H2O2 (2).”
BackgroundSelf-citationKappert, K., Sparwel, J., Sandin, Å., Seiler, A., Siebolts, U., Leppänen, O., Rosenkranz, S., & Östman, A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000246777.30819.85 · Cited by 82
Typical 2‐Cys peroxiredoxins – modulation by covalent transformations and noncovalent interactions
Arán, M., Ferrero, D. S., Pagano, E. A., & Wolosiuk, R. A. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06984.x · Cited by 77
Peroxides and Peroxide-Degrading Enzymes in the Thyroid
Schweizer, U., Chiu, J., & Köhrle, J. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2054 · Cited by 74
Hyperoxidation of Peroxiredoxins: Gain or Loss of Function?
Veal, E. A., Underwood, Z., Tomalin, L. E., Morgan, B. A., & Pillay, C. S. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7214 · Cited by 84
“In support of the principle underlying this hypothesis, phosphorylation has been shown to reduce the thioredoxin peroxidase activity of mammalian Prx1 and thus promote H 2 O 2 - dependent signaling in response to growth factors (16, 19, 97).”
Roles of the KEAP1-NRF2 system in mammalian skin exposed to UV radiation
Ikehata, H., & Yamamoto, M. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.09.038 · Cited by 73
“4 aPTP, active protein tyrosine phosphatase; GPX, glutathione peroxidase; iPTP, inactive 5 PTP; LPO, lipid peroxidation; MMPs, matrix metalloproteinases; PCOOH, 6 phosphatidylcholine hydroperoxide; PRX, peroxiredoxin; PTK, protein tyrosine kinase; 7 SRX, sulfiredoxin; TRX, thioredoxin.”
BackgroundInfluentialThe 5‐HT transporter transactivates the PDGFβ receptor in pulmonary artery smooth muscle cells
Liu, Y., Li, M., Warburton, R. R., Hill, N. S., & Fanburg, B. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-8058com · Cited by 73
Overexpression of Peroxiredoxin 4 Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice
Guo, X., Yamada, S., Tanimoto, A., Ding, Y., Wang, K.-Y., Shimajiri, S., Murata, Y., Kimura, S., Tasaki, T., Nabeshima, A., et al. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4549 · Cited by 73
World, C., Spindel, O. N., & Berk, B. C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226340 · Cited by 69
Benfeitas, R., Selvaggio, G., Antunes, F., Coelho, P. M. B. M., & Salvador, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.007 · Cited by 84
“In turn, Prx2 has also been involved in various signaling processes [76,77].”
BackgroundLatimer, H. R., & Veal, E. A. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2327 · Cited by 68
“…to act as barriers to H2O2 signal transduction and indeed there is plenty of evidence to suggest that Prx inhibit the activation of ROS-activated signalling pathways, including MAPK (Cao et al., 2009; Choi et al., 2005; Kang et al., 2004; Kil et al., 2012; Woo et al., 2010; Yang et al., 2007).”
BackgroundDimer-Oligomer Interconversion of Wild-type and Mutant Rat 2-Cys Peroxiredoxin
Matsumura, T., Okamoto, K., Iwahara, S.-I., Hori, H., Takahashi, Y., Nishino, T., & Abe, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705753200 · Cited by 67
Lee, K. W., Lee, D. J., Lee, J. Y., Kang, D. H., Kwon, J., & Kang, S. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179416 · Cited by 68
Self-citationDual Role of Peroxiredoxin I in Macrophage-derived Foam Cells
Conway, J. P., & Kinter, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605026200 · Cited by 65
Regulation of Protein Tyrosine Phosphatase Oxidation in Cell Adhesion and Migration
Frijhoff, J., Dagnell, M., Godfrey, R., & Östman, A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5643 · Cited by 65
“Following up on earlier studies on the role of PTP oxidation in PDGF-driven restenosis (36, 65), a number of recent studies suggest that PTP oxidation is involved in the pathogenic effects of ROS in many additional cardiovascular diseases.”
Oláhová, M., & Veal, E. A. (2015) · Aging Cell · doi:10.1111/acel.12321 · Cited by 75
“mediated inactivation of protein tyrosine phosphatases (PTP) during growth factor signalling (Choi et al., 2005).”
BackgroundMorin, P., & Storey, K. B. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.01.035 · Cited by 69
Phosphoproteins regulated by heat stress in rice leaves
Chen, X., Zhang, W., Zhang, B., Zhou, J., Wang, Y., Yang, Q., Ke, Y., & He, H. (2011) · Proteome Science · doi:10.1186/1477-5956-9-37 · Cited by 68
“Peroxiredoxins have diverse functions in cellular defense-signaling pathways [25], and 2-Cys peroxiredoxin plays direct roles in cellular-signaling events [25-27].”
BackgroundSilencing of tissue factor pathway inhibitor‐2 gene in malignant melanomas
Nobeyama, Y., Okochi‐Takada, E., Furuta, J., Miyagi, Y., Kikuchi, K., Yamamoto, A., Nakanishi, Y., Nakagawa, H., & Ushijima, T. (2007) · International Journal of Cancer · doi:10.1002/ijc.22637 · Cited by 62
Kang, D. H., Lee, D. J., Lee, S., Lee, S.-Y., Jun, Y., Kim, Y., Kim, Y., Lee, J., Lee, D., Lee, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00054-0 · Cited by 63
Self-citationProtection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis
Zhao, W., Fan, G., Zhang, Z.-G., Bandyopadhyay, A., Zhou, X., & Kranias, E. G. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0764-6 · Cited by 62
“Peroxiredoxin II deficiency also resulted in increased production of H2O2, enhanced activation of platelet-derived growth factor (PDGF) receptor and phospholipase Cc1, subsequently leading to increased cell proliferation and migration in response to PDGF [5].”
Kim, K., Alam, I., Lee, K., Sharmin, S. A., Kwak, S., Lee, S. Y., & Lee, B. (2009) · Biotechnology Letters · doi:10.1007/s10529-009-0185-0 · Cited by 63
Self-citationWang, S. B., Jang, J. Y., Chae, Y. H., Min, J. H., Baek, J. Y., Kim, M., Park, Y., Hwang, G. S., Ryu, J., & Chang, T.-S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.01.018 · Cited by 67
Peroxiredoxins as Potential Targets for Cardiovascular Disease
Jeong, S., Park, J., & Oh, G. T. (2021) · Antioxidants · doi:10.3390/antiox10081244 · Cited by 69
“The overexpression of catalase and peroxiredoxin (Prdx) 2 and inhibition of antioxidant production inhibit the PDGF-induced migration of VSMCs, implying that the PDGF-induced migration of VSMCs is dependent on ROS generation [11,62,64].”
BackgroundSuppression of Peroxiredoxin 4 in Glioblastoma Cells Increases Apoptosis and Reduces Tumor Growth
Kim, T. H., Song, J., Llaguno, S. R. A., Murnan, E., Liyanarachchi, S., Palanichamy, K., Yi, J.-Y., Viapiano, M. S., Nakano, I., Yoon, S. O., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042818 · Cited by 67
Lǚ, G., Xiao, H., Li, G. X., Picinich, S. C., Chen, Y., Liu, A., Lee, M. J., Loy, S., & Yang, C. S. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp332 · Cited by 61
Liu, J., Zhou, S., Ren, J. M., Wu, C., & Zhao, Y. (2017) · The Analyst · doi:10.1039/c7an01280b · Cited by 60
2-Cys Peroxiredoxins: Emerging Hubs Determining Redox Dependency of Mammalian Signaling Networks
Park, J., Lee, S., Lee, S., & Kang, S. W. (2014) · International Journal of Cell Biology · doi:10.1155/2014/715867 · Cited by 64
“Also, Prx2 negatively regulates the PDGF-induced tyrosine phosphorylation in fibroblast and vascular smooth muscle cells [30].”
BackgroundSelf-citationLee, C., Park, H., So, H. H., Kim, H. J., Lee, K. S., Choi, W. S., Lee, H. M., Won, K., Yoon, T. J., Park, T., et al. (2006) · PROTEOMICS · doi:10.1002/pmic.200600124 · Cited by 63
Self-citationYe, W., Ni, Z., Yicheng, S., Pan, H., Huang, Y., Xiong, Y., & Liu, T. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4887 · Cited by 64
“…of the intracellular domain, or promotes phosphorylation of tyrosine residues that activate specific target proteins, thereby transmitting signals into the cell, activating downstream signalling pathways, and directly inducing cell proliferation, differentiation, growth and development (35,36).”
Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury
Li, Q., Zhang, Y., Marden, J. J., Banfi, B., & Engelhardt, J. F. (2008) · Biochemical Journal · doi:10.1042/bj20071534 · Cited by 58
“For example, localized inactivation of the antioxidant enzyme peroxiredoxin II by H2O2 has been shown to regulate PDGF signalling by controlling the redox-dependent inactivation of PTPs that are required for PDGF receptor inactivation [ 39 ].”
Characterization of plant sulfiredoxin and role of sulphinic form of 2-Cys peroxiredoxin
Iglesias-Baena, I., Barranco-Medina, S., Lázaro-Payo, A., López-Jaramillo, J., Sevilla, F., & Lázaro, J.-J. (2010) · Journal of Experimental Botany · doi:10.1093/jxb/erq016 · Cited by 66
“Choi et al. (2005) have demonstrated that human Prx II is a negative regulator of platelet-derived growth factor (PDGF) and Prx II deficiency results in increased cell proliferation.”
BackgroundInfluentialExpression of peroxiredoxin 1 and 4 promotes human lung cancer malignancy.
Jiang, H., Wu, L., Mishra, M., Chawsheen, H. A., & Wei, Q. (2014) · Europe PMC (PubMed Central) · Cited by 68
Thioredoxin in Vascular Biology: Role in Hypertension
Ebrahimian, T., & Touyz, R. M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1985 · Cited by 63
“-stimulated H 2 O 2 levels were reduced or increased respectively (4).”
Peroxiredoxin Stabilization of DE-Cadherin Promotes Primordial Germ Cell Adhesion
DeGennaro, M., Hurd, T. R., Siekhaus, D. E., Biteau, B., Jasper, H., & Lehmann, R. (2011) · Developmental Cell · doi:10.1016/j.devcel.2010.12.007 · Cited by 64
“signaling, Prdx2 has been shown to negatively regulate plateletderived growth factor (PDGF) (Choi et al., 2005).”
BackgroundJunior, C. A. T., de Oliveira, M. A., Horta, B. B., Zara, F. J., & Netto, L. E. S. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.09.008 · Cited by 66
Verschoor, M. L., Wilson, L. A., & Singh, G. (2010) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-135 · Cited by 57
Peroxiredoxin II preserves cognitive function against age-linked hippocampal oxidative damage
Kim, S., Jin, M.-H., Kim, Y. S., Lee, S., Cho, Y. S., Cho, K.-J., Lee, K., Kim, Y. I., Kim, G. W., Kim, J., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.017 · Cited by 61
Self-citationBoulos, S., Meloni, B. P., Arthur, P. G., Bojarski, C., & Knuckey, N. W. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21429 · Cited by 55
Peroxiredoxin-controlled G-CSF signalling at the endoplasmic reticulum–early endosome interface
Palande, K. K., Roovers, O., Gits, J., Verwijmeren, C., Iuchi, Y., Fujii, J., Neel, B. G., Karisch, R., Tavernier, J. H., & Touw, I. P. (2011) · Journal of Cell Science · doi:10.1242/jcs.089656 · Cited by 59
“Prdx1 and Prdx2 were found to associate with PDGFR and to modulate signalling by controlling H2O2 levels at the plasma membrane (Choi et al., 2005; Woo et al., 2010).”
BackgroundAn unexplored role for Peroxiredoxin in exercise-induced redox signalling?
Wadley, A. J., Aldred, S., & Coles, S. J. (2016) · Redox Biology · doi:10.1016/j.redox.2015.10.003 · Cited by 54
Prx I Suppresses K-ras-Driven Lung Tumorigenesis by Opposing Redox-Sensitive ERK/Cyclin D1 Pathway
Park, Y., Kim, S., Lee, B.-K., Kim, H.-S., Song, I.-S., Shin, H.-J., Han, Y., Chang, K.-T., Kim, J., Lee, D., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4421 · Cited by 54
“Indeed, numerous Prx isotypes, including Prx IV, involve the signaling pathways triggered by growth factors, such as granulocyte colony-stimulating factor and platelet-derived growth factor, via interaction with their receptors (11, 42).”
BackgroundSelf-citationHyperoxidized peroxiredoxin 2 interacts with the protein disulfide- isomerase ERp46
Pace, P., Peskin, A. V., Han, M., Hampton, M. B., & Winterbourn, C. C. (2013) · Biochemical Journal · doi:10.1042/bj20130030 · Cited by 57
CD36 Enhances Vascular Smooth Muscle Cell Proliferation and Development of Neointimal Hyperplasia
Yue, H., Febbraio, M., Klenotic, P. A., Kennedy, D. J., Wu, Y., Chen, S., Gohara, A. F., Li, O., Belcher, A. M., Kuang, B., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.312186 · Cited by 57
Reactive oxygen species augment B-cell-activating factor expression
Moon, E.-Y., Lee, J. H., Oh, S.-Y., Ryu, S.-K., Kim, H.-M., Kwak, H.-S., & Yoon, W.-K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.02.007 · Cited by 57
Self-citationReining in H2O2 for Safe Signaling
Tolédano, M. B., Planson, A., & Delaunay, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.003 · Cited by 58
Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae
Kim, C. H., & Leitch, H. A. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103367 · Cited by 56
Zambuzzi, W. F., Milani, R., & Teti, A. M. (2010) · Biochimie · doi:10.1016/j.biochi.2010.01.002 · Cited by 55
Targeted modulation of reactive oxygen species in the vascular endothelium
Shuvaev, V. V., & Muzykantov, V. R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.022 · Cited by 50
“Endothelial target MM Functions Vascular expression, EC density, internalization PECAM-1 130 kDa Component of intercellular junctions, interaction with cytoskeleton, ITIM-mediated inhibitory function, mechanoreceptor Constitutively expressed by EC of all blood and lymphatic vessels at high density.”
BackgroundInfluentialTargeting Cellular Antioxidant Enzymes for Treating Atherosclerotic Vascular Disease
Kang, D. H., & Kang, S. W. (2013) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2013.015 · Cited by 59
“For example, Prx II was shown to suppress the proliferation and migration of smooth muscle cells (SMCs) with the site-selective phosphorylation of the PDGF receptor and increased the neointimal thickness of SMCs in a ballooninjured carotid artery (Choi et al., 2005).”
BackgroundSelf-citationKubo, E., Singh, D. P., Fatma, N., & Akagi, Y. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.03.019 · Cited by 50
Won, H., Lim, S., Jang, M., Kim, Y., Rashid, M. A., Jyothi, K. R., Dashdorj, A., Kang, I., Ha, J., & Kim, S. S. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3952 · Cited by 57
Discovery of gliotoxin as a new small molecule targeting thioredoxin redox system
Choi, H. S., Shim, J. S., Kim, J.-A., Kang, S. W., & Kwon, H. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.139 · Cited by 49
Self-citationInvolvement of Peroxiredoxin I in Protecting Cells from Radiation-Induced Death
Zhang, B., Su, Y., Ai, G., Wang, Y., Wang, T., & Wang, F. (2005) · Journal of Radiation Research · doi:10.1269/jrr.46.305 · Cited by 52
Boucher, I. W., McMillan, P. J., Gabrielsen, M., Akerman, S. E., Brannigan, J. A., Schnick, C., Brzozowski, A. M., Wilkinson, A. J., & Müller, S. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05303.x · Cited by 53
“…article is available free online at www.blackwell-synergy.com Ian W. Boucher,1† Paul J. McMillan,2† Mads Gabrielsen,2‡ Susan E. Akerman,2§ James A. Brannigan,1 Claudia Schnick,1 Andrzej M. Brzozowski,1 Anthony J. Wilkinson1 and Sylke Müller2* 1Structural Biology Laboratory, Department of Chemistry,”
BackgroundPark, H., Noh, A. L. S. M., Kang, J., Sim, J.-S., Lee, D., & Yim, M. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5748 · Cited by 50
“For example, a previous study showing the specific involvement of PrxII in smooth muscle cell proliferation suggests the potential therapeutic use of PrxII for the inhibition of atherogenic lesion progression (10).”
Self-citationLei, H., & Kazlauskas, A. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00839-13 · Cited by 48
Molavian, H. R., Tonekaboni, A. M., Kohandel, M., & Sivaloganathan, S. (2015) · Scientific Reports · doi:10.1038/srep13620 · Cited by 56
Hong, J. H., Moon, S. J., Byun, H. M., Kim, M. S., Jo, H., Bae, Y. S., Lee, S.-I., Bootman, M. D., Roderick, H. L., Shin, D. M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601726200 · Cited by 48
Self-citationHuman synthetic lethal inference as potential anti-cancer target gene detection
Pueyo, N. C., Munteanu, A., Solé, R. V., & Rodríguez‐Caso, C. (2009) · BMC Systems Biology · doi:10.1186/1752-0509-3-116 · Cited by 57
“It is interesting to mention that PRDX2 has been associated to cell proliferation and cell migration by regulation of the PDGF signalling [67].”
BackgroundManganese oxide particles as cytoprotective, oxygen generating agents
Tootoonchi, M. H., Hashempour, M., Blackwelder, P. L., & Fraker, C. A. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.07.006 · Cited by 49
Analysis of NOD2-mediated Proteome Response to Muramyl Dipeptide in HEK293 Cells
Weichart, D. H., Gobom, J., Klopfleisch, S., Häsler, R., Gustavsson, N., Billmann-Born, S., Lehrach, H., Seegert, D., Schreiber, S., & Rosenstiel, P. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505986200 · Cited by 55
Zeng, L., Li, Y., Yang, J., Wang, G., Margariti, A., Xiao, Q., Zampetaki, A., Yin, X., Mayr, M., Mori, K., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305420 · Cited by 46
“PDGF is a well-known mitogenic factor for mature SMC proliferation.(56) Several signaling pathways have been reported to be activated by PDGF/PDGFRβ binding, such as mitogenactivated protein kinases, PI3K/Akt, and basic fibroblast growth factor releasing.”
BackgroundDagnell, M., Pace, P., Cheng, Q., Frijhoff, J., Östman, A., Arnér, E. S. J., Hampton, M. B., & Winterbourn, C. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.793745 · Cited by 49
“Prx2 reacts readily with H2O2 and is recycled primarily by the Trx/TrxR system (21,22), and evidence for crosstalk between PTPs and Prx2 during PDGF signaling has been described (23).”
BackgroundMethodMiyamoto, N., Izumi, H., Miyamoto, R., Kubota, T., Tawara, A., Sasaguri, Y., & Kohno, K. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3061 · Cited by 46
Slavica, A., Dib, I., & Nidetzky, B. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8061-8068.2005 · Cited by 54
Novel Protective Mechanism against Irreversible Hyperoxidation of Peroxiredoxin
Seo, J. H., Lim, J. C., Lee, D., Kim, K. S., Piszczek, G., Nam, H. W., Kim, Y. S., Ahn, T., Yun, C., Kim, K., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900641200 · Cited by 53
Self-citationWei, X., Sun, Y., Wu, Y., Zhu, J., Gao, B., Yan, H., Zhao, Z., Zhou, J., & Jing, Z. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0588-0 · Cited by 45
“Dysfunctions of proliferation and migration in VSMC has been reported to participate in vascular diseases [7, 8].”
BackgroundNox enzymes in allergic airway inflammation
van der Vliet, A. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.03.004 · Cited by 51
“Specificity in oxidative signaling is ensured by strict spatial localization of NOX activation in association with the cytoskeleton [35, 36] or membrane rafts [37-39] and by direct interactions with locally present oxidant-sensitive proteins targets [6, 39, 40], which allows for effective oxidative signaling within di…”
Bowers, R. R., Manevich, Y., Townsend, D. M., & Tew, K. D. (2012) · Biochemistry · doi:10.1021/bi301006w · Cited by 47
“However, hyper-oxidized peroxiredoxins are not detectable during physiological H2O2 signaling (47) and phosphorylation of Tyr194 of membrane associated PrxI inactivates it following growth factor stimulation during wound healing allowing a transient accumulation of H2O2 around membranes (48).”
BackgroundKropotov, A., Serikov, V. B., Suh, J. H., Smirnova, A., Bashkirov, V. I., Zhivotovsky, B., & Tomilin, N. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05265.x · Cited by 46
Tang, H.-M. V., Siu, K., Wong, C., & Jin, D. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000697 · Cited by 52
Quantitative measures for redox signaling
Pillay, C. S., Eagling, B. D., Driscoll, S. R. E., & Rohwer, J. M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.199 · Cited by 49
Wang, J., Song, J., Qi, H., Zhang, H., Wang, L., Zhang, H., Cui, C., Ji, G., Muhammad, S., Sun, G., et al. (2023) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2023.107876 · Cited by 46
Xu, Q., Malecka, K. L., Fink, L., Jordan, E. J., Duffy, E., Kolander, S., Peterson, J. R., & Dunbrack, R. L. (2015) · Science Signaling · doi:10.1126/scisignal.aaa6711 · Cited by 42
A Comparative Review of the Effect of Microcystin-LR on the Proteome
Welten, R. D., Meneely, J. P., & Elliott, C. T. (2019) · Exposure and Health · doi:10.1007/s12403-019-00303-1 · Cited by 46
The Lipoxin A4 Receptor Is Coupled to SHP-2 Activation
Mitchell, D., O'Meara, S. J., Gaffney, A., Crean, J. K. G., Kinsella, B. T., & Godson, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611004200 · Cited by 43
Vuorinen, K., Ohlmeier, S., Leppäranta, O., Salmenkivi, K., Myllärniemi, M., & Kinnula, V. L. (2008) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2008.951806 · Cited by 40
“Nitrotyrosine was used as a marker for oxidative/nitrosative stress in the IPF/UIP lungs because it reflects both superoxide (through myeloperoxidase) and nitric oxide– mediated reactions in the cells (Davis et al. 2001).”
MethodImplications and progression of peroxiredoxin 2 (PRDX2) in various human diseases
Balasubramanian, P., Vijayarangam, V., Deviparasakthi, M. K. G., Palaniyandi, T., Ravi, M., Natarajan, S., Viswanathan, S., Baskar, G., Wahab, M. R. A., & Surendran, H. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.155080 · Cited by 43
Metadata
- Authors
- Choi, M. H., Lee, I. K., Kim, G. W., Kim, B. U., Han, Y.-H., Yu, D.-Y., Park, H. S., Kim, K. Y., Lee, J. S., Choi, C., Bae, Y. S., Lee, B. I., Rhee, S. G., & Kang, S. W.
- Affiliations
- Ewha Womans University (KR)
- Yonsei University (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- National Institutes of Health (US)
- Corresponding author
- Rhee, Sue Goo
- Kang, Sang Won
- ORCID
- Venue
- Nature
- Published
- 2005-05
- Volume
- 435
- Issue
- 7040
- Pages
- 347-353
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1974966731
- Cited by
- 403
- References
- 23
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 13 · 2019: 21 · 2018: 16 · 2017: 26 · 2016: 10 · 2015: 20 · 2014: 19 · 2013: 15 · 2012: 22
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.nature.com
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- KRIBB Repository (submittedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- peroxiredoxin 2, platelet-derived growth factor, PDGF signaling, PDGF receptor, hydrogen peroxide, vascular remodeling, restenosis, neointimal thickening, vascular smooth muscle cells, phospholipase C-gamma1, protein tyrosine phosphatase, cell proliferation, cell migration
- MeSH terms
- Animals, Aorta, Carotid Arteries, Cells, Cultured, Enzyme Activation, Humans, Peroxidases, Phosphorylation, Platelet-Derived Growth Factor, Protein Binding, Signal Transduction, Receptors, Platelet-Derived Growth Factor, Neovascularization, Physiologic, Phosphotyrosine, Coronary Restenosis, Myocytes, Smooth Muscle, Mice, Peroxiredoxins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.